Nilda Mesa - Jun 26, 2021 Form 4/A - Amendment Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Jun 26, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/16/2022, 03:56 PM
Date Of Original Report
Jun 29, 2021
Next filing
Jul 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $0 +1.68K +33.87% $0.00 6.64K Jun 26, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Restricted Stock Units Options Exercise $0 -1.68K -100% $0.00* 0 Jun 26, 2021 Common Stock 1.68K $0.00 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was originally reported on a Form 4 filed on June 29, 2021, which incorrectly reported the amount beneficially owned following reported transaction as 1,680 due to a clerical error.
F2 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F3 The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
F4 The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.